Nomura Asset Management CO LTD Nektar Therapeutics Transaction History

Nomura Asset Management CO LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$15.87 - $23.12 $436,425 - $635,800	-27,500 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$16.91 - $36.27 $2,536 - $5,440	150 Added 0.55%	27,500 $501,000
Q2 2019 Aug 13, 2019	SELL	$31.0 - $36.3 $6,510 - $7,622	-210 Reduced 0.76%	27,350 $973,000
Q1 2019 May 10, 2019	BUY	$31.58 - $46.35 $104,214 - $152,955	3,300 Added 13.6%	27,560 $926,000
Q4 2018 Feb 12, 2019	SELL	$30.43 - $56.65 $51,365 - $95,625	-1,688 Reduced 6.51%	24,260 $797,000

Q3 2018 Nov 07, 2018	BUY	$46.46 - $68.49 $147,882 - $218,003	3,183 Added 13.98%	25,948 $1.58 Million
Q2 2018 Aug 03, 2018	BUY	$46.25 - $104.45 $1.05 Million - $2.38 Million	22,765 New	22,765 $1.11 Million

15.6M

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $10.6B
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.